Graesser v. IQVIA RDS Inc.

CourtDistrict Court, D. Colorado
DecidedSeptember 12, 2023
Docket1:21-cv-01337
StatusUnknown

This text of Graesser v. IQVIA RDS Inc. (Graesser v. IQVIA RDS Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Graesser v. IQVIA RDS Inc., (D. Colo. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Chief Judge Philip A. Brimmer

Civil Action No. 21-cv-01337-PAB-KAS

KRISTEN GRAESSER,

Plaintiff,

v.

IQVIA RDS INC., a North Carolina corporation,

Defendant. _____________________________________________________________________

ORDER _____________________________________________________________________

This matter is before the Court on Defendant’s Motion for Summary Judgment [Docket No. 54] filed by defendant IQVIA RDS Inc. (“IQVIA”) on September 30, 2022 and plaintiff Kristen Graesser’s Unopposed Motion Seeking Leave to File Sur-reply [Docket No. 72].1 The Court has jurisdiction pursuant to 28 U.S.C. § 1332. This dispute concerns whether Graesser should have been paid a bonus that Graesser alleges she earned in 2020 working for IQVIA. I. BACKGROUND A. Undisputed Facts2 IQVIA is a multi-national pharmaceutical company headquartered in North Carolina.

1 Plaintiff’s motion for leave to file a sur-reply requests an opportunity to address a case, Cahey v. Int’l Bus. Machines Corp. (Cahey II), No. 20-cv-00781-NYW, 2021 WL 5384526, at *12 (D. Colo. Nov. 18, 2021), that was decided after she filed her response, but before defendant filed its reply. Docket No. 72 at 1-2, ¶¶ 2-4. The motion is unopposed. Id. at 2, ¶ 6. The Court will grant Graesser’s motion and consider her sur- reply. 2 The following facts are undisputed unless otherwise indicated. Docket No. 54 at 2, ¶¶ 1-2. In 2020, Sebastian Antonelli acted as the Regional Manager of IQVIA’s American Central Nervous System (“CNS”) medical team. Id., ¶ 4. IQVIA employed Graesser as an Associate Medical Director (“AMD”) on the American CNS medical team from May 6, 2019 until January 22, 2021.3 Id. at 3, 7, 13, ¶¶ 5-6, 20,

45. AMDs report to Regional Managers, and Graesser reported to Antonelli. Id. at 3, ¶¶ 5-6. IQVIA provides AMDs with salary-based pay. Id., ¶ 7. IQVIA also has a non-salary compensation program called the Annual Incentive Plan (“AIP”). Id. IQVIA’s AIP sets a baseline amount that an employee may be eligible to earn as a bonus. Id., ¶ 9. IQVIA provided an offer letter to Graesser that stated: You may participate in non-salary compensation programs as may be available, including an annual cash incentive plan which may be made available to company employees; subject to applicable terms, conditions and eligibility requirements of these plans and at the plan administrator’s discretion. Your bonus target for the plan currently in effect will be 15%. This bonus is earned and awarded at the end of the first quarter of the following year, if the participant is employed in good standing at the time of payment. Incentive payout is prorated based on start date and time worked. Your start date must occur on or before September 30 to be eligible to participate in an incentive plan for the year. Id. at 7, ¶ 21; Docket No. 65-5 at 2.4 On March 13, 2020, Graesser was awarded

3 Graesser neither admits nor denies her start date or end date at IQVIA. See Docket No. 65 at 5, 10, ¶¶ 20, 45. The Court will deem these facts admitted. See Fed. R. Civ. P. 56(e)(2) (“If a party . . . fails to properly address another party’s assertion of fact” the court may, “consider the fact undisputed for purposes of the motion.”); Practice Standards (Civil case), Chief Judge Philip A. Brimmer, § III.F.3.b.ix. (noting that a failure to properly admit or deny facts “may cause the Court to deem certain facts as admitted”). 4 Graesser attaches the entire offer letter to her response at Docket No. 65-5. IQVIA provides the entire letter at Docket No. 71-1. 2 a bonus of $12,597.14 for the 2019 AIP year. Docket No. 54 at 8, ¶ 24. The AIP is defined by IQVIA’s “AIP Rules Document.” Id. at 4, ¶ 11. There is no evidence Graesser was provided with the AIP Rules Document. Docket No. 65 at 11, ¶ 2.5 The AIP allows for discretionary bonuses that are not guaranteed. Docket No. 54 at 4, ¶ 12.6 The AIP Rules Document states that “IQVIA reserves the right to adjust

(including by reduction to zero) an individual’s payment hereunder at any time and for any reason.” Id., ¶ 13 (quoting Docket No. 54-6 at 7).7 Each global medical team management group can set parameters regarding the employees that may be eligible for bonuses, such as allowing employees that

5 IQVIA does not cite undisputed evidence that Graesser was provided with the AIP Rules Document or made aware that it existed other than the reference to “plans” in her offer letter. IQVIA states that candidates and new employees may discuss “the details of IQVIA’s AIP with recruiters” and with IQVIA’s benefits and compensation departments. Docket No. 54 at 4, ¶ 10. In support, IQVIA cites declarations from Matthew McKeever, an employee at IQVIA, and Sebastian Antonelli that “IQVIA’s AIP Plan Rules Document . . . is easily accessible to employees at all times on IQVIA’s intranet and a link for which is sent via email to every employee each year.” Docket No. 54-1 at 2, ¶ 8; Docket No. 54-2 at 2, ¶ 5. IQVIA also states that the AIP Plan Rules Document is emailed to every employee each year and is easily accessible to employees. Docket No. 54 at 4, ¶ 11. In support, IQVIA cites an email that IQVIA sent to employees that is dated April 1, 2021, after Graesser resigned, describing the AIP. Docket No. 54-7 at 1. None of IQVIA’s undisputed statements of fact or cited evidence suggests anyone informed Graesser of the AIP Rules Plan Document before her resignation. The Court will deem this fact admitted. 6 Graesser denies this fact because “Defendant’s references to that document as ‘AIP Plan Rules Document’ and implications that Exhibit F established the terms or conditions of any agreement between the Parties are patent mischaracterizations.” Docket No. 65 at 4, ¶ 12. This is not responsive to IQVIA’s statement of fact. The Court will deem this fact admitted. See Fed. R. Civ. P. 56(e)(2); Practice Standards (Civil case), Chief Judge Philip A. Brimmer, § III.F.3.b.ix. 7 Graesser denies this fact because “Exhibit F was not part of any agreement that existed between the Parties.” Docket No. 65 at 4, ¶ 13. This is not responsive to IQVIA’s statement of fact. The Court will deem this fact admitted. 3 received a high enough score on their annual performance review to be eligible for a potential bonus under the AIP. Id. at 6-7, ¶ 18.8 The CNS management team decided that any employee who received an overall 2020 annual performance rating of 4 or 5, the lowest on a 5 point scale, would not be eligible for a bonus under the AIP for that year. Id. at 7, ¶ 19.9

On December 30, 2020, Antonelli gave Graesser an overall rating of 4, “Below Expectations,” on her 2020 annual performance review. Id. at 12, ¶ 44.10 Graesser voluntarily resigned from her position at IQVIA on January 4, 2021. Id.

8 Graesser denies this fact stating that “[t]here is no evidence supporting the allegation[s]” in IQVIA’s statement of fact. Docket No. 65 at 5, ¶ 18. IQVIA cites Matthew McKeever’s declaration which states: “[e]ach global medical team management group can, and with senior business approval generally does, set parameters regarding the employees that may be eligible for bonuses in the first place, such as only allowing employees that received a high enough score on their annual performance review to be eligible for a potential bonus under the AIP.” Docket No. 54-1 at 3, ¶ 11. The Court finds that IQVIA has cited evidence supporting this fact. Thus, the Court will deem this fact admitted. 9 Graesser denies this fact because it was not communicated to her. Docket No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Bullington v. United Air Lines, Inc.
186 F.3d 1301 (Tenth Circuit, 1999)
Bausman v. Interstate Brands Corp.
252 F.3d 1111 (Tenth Circuit, 2001)
Faustin v. City and County
423 F.3d 1192 (Tenth Circuit, 2005)
Geras v. International Business MacHines Corp.
638 F.3d 1311 (Tenth Circuit, 2011)
Barnes v. Van Schaack Mortgage
787 P.2d 207 (Colorado Court of Appeals, 1990)
Hernandez v. Ray Domenico Farms, Inc.
2018 CO 15 (Supreme Court of Colorado, 2018)
Peace v. Parascript Management, Inc.
59 F. Supp. 3d 1020 (D. Colorado, 2014)
Hallmon v. Advance Auto Parts, Inc.
921 F. Supp. 2d 1110 (D. Colorado, 2013)
Carmen NIETO v. CLARK'S MARKET, INC.
488 P.3d 1140 (Supreme Court of Colorado, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
Graesser v. IQVIA RDS Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/graesser-v-iqvia-rds-inc-cod-2023.